Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Endocrine Practice
Journal
Overview
Identity
Overview
Publication Venue For
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)
. 28:528-562.
2022
Diversity, Equity and Inclusion in Endocrinology: A Survey and Vision for the Future.
2022
Attitudes, Perceptions, and Practices Among Endocrinologists Managing Obesity.
. 28:179-184.
2022
Is Obesity or Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second-Generation Medications
. 28:214-222.
2022
Incidental Pituitary Cysts in Children: Does Growth Hormone Treatment Affect Cyst Size?
. 27:1128-1132.
2021
Pediatric Endocrinology: Perspectives of Pediatric Endocrinologists Regarding Career Choice and Recruitment of Trainees
. 27:743-748.
2021
Arterial Stiffness: Comment on the Article by Pavloska et al
. 27:640-641.
2021
COVID-19 & obesity: Beyond BMI
. 26:923-925.
2020
The role of heteroplasmy in the diagnosis and management of maternally inherited diabetes and deafness
. 26:241-246.
2020
Consensus statement by the American Association of clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary
. 26:107-139.
2020
CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY
. 25:1346-1359.
2019
Commentary from the American association of clinical endocrinologists on the U.S. preventive services task force recommandations regarding weight loss interventions
. 25:394-395.
2019
Commentary on a direct comparison of the ATA and TI-RADS ultrasound scoring systems
. 25:503-505.
2019
Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm – 2019 executive summary
. 25:69-100.
2019
Dysglycemia-based chronic disease: An American association of clinical endocrinologists position statement
. 24:995-1011.
2018
Clinical characteristics and sequelae of severe hypertriglyceridemia in pediatrics
. 24:789-795.
2018
Application of the AACE/ACE advanced framework for the diagnosis of obesity and cardiometabolic disease staging in a general population from 3 regions of Venezuela: The vemsols study results
. 24:6-13.
2018
Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary
. 24:91-120.
2018
To the editor: Author response to Dr. Zhu
. 23:888.
2017
Letter to the Editor
. 23:749-750.
2017
Adiposity-based chronic disease as a new diagnostic term: The American association of clinical endocrinologists and American college of endocrinology position statement
. 23:372-378.
2017
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY
. 23:207-238.
2017
Patient-centered care of the patient with obesity
. 22:1-21.
2016
Effects of liraglutide 3.0 mg on weight and risk factors in hispanic versus non-hipanic populations: Subgroup analysis from scale randomized trials
. 22:1277-1287.
2016
American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity: Executive summary
. 22:842-884.
2016
Transculturalization recommendations for developing Latin American clinical practice algorithms in endocrinology - Proceedings of the 2015 pan-American workshop by the American association of clinical endocrinologists and American college of endocrinology
. 22:477-501.
2016
American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity
. 22:1-203.
2016
Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2016 executive summary
. 22:84-113.
2016
Consensus statement by the American association of clinical endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management algorithm - 2015 executive summary
. 21:1403-1414.
2015
Diabetes and prediabetes are significantly higher in morbidly obese children compared with obese children
. 21:1046-1053.
2015
American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015
. 21:1-87.
2015
AACE/ACE comprehensive diabetes management algorithm 2015
. 21:438-447.
2015
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY
. 21:413-437.
2015
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY - CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN - 2015.
. 21 Suppl 1:1-87.
2015
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY
. 21:413-437.
2015
Diabetes status and race are associated with cardiovascular risk markers in obese adolescents
. 21:165-173.
2015
American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action.
. 20:956-976.
2014
American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease.
. 20:977-989.
2014
Erratum: AACE Obesity Position Statement (Endocrine Practice (2012) 18 (642-648))
. 19:1072.
2013
Glycemic control and diabetic dyslipidemia in adolescents with type 2 diabetes
. 19:972-979.
2013
Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: Cosponsored by the American association of clinical endocrinologists/the american college of endocrinology and the obesity society: Executive summary
. 19:875-887.
2013
New tools for weight-loss therapy enable a more robust medical model for obesity treatment: Rationale for a complications-centric approach
. 19:864-874.
2013
American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement
. 19:1-48.
2013
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: Cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery
. 19:337-372.
2013
AACE comprehensive diabetes management algorithm 2013.
. 19:327-336.
2013
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.
. 19:536-557.
2013
In response
. 19:170.
2013
The clinical approach to the detection of lipodystrophy - An AACE consensus statement
. 19:107-116.
2013
Use of available glucose-lowering agents in patients with different levels of renal impairment
. 19:14-18.
2013
American association of clinical endocrinologists' position statement on obesity and obesity medicine
. 18:642-648.
2012
Safety and feasibility of laparoscopic resection for large (≥6 cm) pheochromocytomas without suspected malignancy
. 18:720-726.
2012
Preoperative ultrasonography findings predict the need for repeated surgery in papillary thyroid cancer
. 18:403-409.
2012
Three large, functioning cystic parathyroid adenomas
. 18.
2012
Diagnosis and management of pheochromocytoma in an academic hospital 3 years after formation of a pheochromocytoma interest group
. 17:356-362.
2011
Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas
. 17.
2011
Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
. 16:617-628.
2010
Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
. 16:629-640.
2010
Evaluation of vitamin d repletion regimens to correct vitamin d status in adults
. 15:95-103.
2009
Symptomatic hyperprolactinemia from an ectopic pituitary adenoma located in the clivus
. 15:143-148.
2009
Visual vignette
. 14:651.
2008
Diagnosis and management of prediabetes in the continuum of hyperglycemia - When do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists
. 14:933-946.
2008
Pheochromocytoma in patients suspected of harboring adrenal metastasis: Management and clinical predictors
. 14:967-972.
2008
Visual vignette
. 14:651.
2008
Vitamin D status in United States war veterans
. 14:127-128.
2008
Cardiovascular disease prevention and care in latino and hispanic subjects
. 13:77-85.
2007
Calciphylaxis in the absence of end-stage renal disease
. 12:406-410.
2006
Reversible subclinical hypothyroidism in the presence of adrenal insufficiency
. 12:572-575.
2006
Vaginal bleeding and galactorrhea in a child with ovarian steroid cell tumor
. 11:346-349.
2005
Catecholamine excess in pheochromocytoma inducing insulin resistance
. 10:149-152.
2004
Visual vignette
. 10:384.
2004
Artifactually low hemoglobin A1c caused by use of dapsone
. 8:370-372.
2002
Effect of thiazolidinediones on high-density lipoprotein subfractions
. 8:102-104.
2002
Lipoprotein effects of different thiazolidinediones in clinical practice
. 8:406-410.
2002
Long-term efficacy of triple oral therapy for type 2 diabetes mellitus
. 8:271-275.
2002
Conversion from troglitazone to rosiglitazone
. 7:326.
2001
Tissue triglyceride levels in type 2 diabetes and the role of thiazolidinediones in reversing the effects of tissue hypertriglyceridemia: Review of the evidence in animals and humans
. 7:135-138.
2001
Use of soy protein supplement and resultant need for increased dose of levothyroxine
. 7:193-194.
2001
How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?
. 6:293-295.
2000
Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy.
. 6:357-360.
2000
Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins.
. 6:477-478.
2000
C-Peptide utilization in clinical practice: effect on treatment and outcome of diabetes in a series of cases.
. 5:114-118.
1999
Triple oral antidiabetic therapy in type 2 diabetes mellitus.
. 4:146-147.
1998
Identity
International Standard Serial Number (issn)
1530-891X
Electronic International Standard Serial Number (eissn)
1934-2403